SEC Form 4 · accession 0001209191-18-046821
Verrica Pharmaceuticals Inc. · VRCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul B Manning
Director · 10% Owner
Period of report
Jun 19, 2018
Accepted (ET)
Aug 15, 2018 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660334
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 19, 2018 | P | 200,000 | $15.00 | A | 7,987,783 | D | |
| Common StockF3 | Jun 19, 2018 | P | 100,000 | $15.00 | A | 1,260,244 | I | See Footnote |
| Common StockF4 | holding | — | — | — | 256,634 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represent the total number of shares owned by the Reporting Person including the shares acquired on August 10, 2018.
- F2Consists of 7,754,783 shares of common stock held by Mr. Manning and 233,000 shares of common stock held by Mr. Manning jointly with his spouse.
- F3The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB.
- F4The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.